English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
  Brain glutamate cycle metabolites and medication interference in BD I Patients: H1-MRS Studies

Soeiro-de-Souza, M., Henning, A., Machado-Vieira, R., Moreno, R., Pastorello, B., Leite, C., et al. (2017). Brain glutamate cycle metabolites and medication interference in BD I Patients: H1-MRS Studies. Bipolar Orders, 19(Supplement 1), 25-25.

Item is

Basic

show hide
Item Permalink: http://hdl.handle.net/21.11116/0000-0000-C594-A Version Permalink: http://hdl.handle.net/21.11116/0000-0001-018D-F
Genre: Meeting Abstract

Files

show Files

Locators

show
hide
Locator:
Link (Any fulltext)
Description:
-

Creators

show
hide
 Creators:
Soeiro-de-Souza, M, Author
Henning, A1, 2, Author              
Machado-Vieira, R, Author
Moreno, RA, Author
Pastorello, BF, Author
Leite, C, Author
Vallada, H, Author
Otaduy, MC, Author
Affiliations:
1Max Planck Institute for Biological Cybernetics, Max Planck Society, ou_1497794              
2Research Group MR Spectroscopy and Ultra-High Field Methodology, Max Planck Institute for Biological Cybernetics, Max Planck Society, ou_2528692              

Content

show
hide
Free keywords: -
 Abstract: Bipolar disorder has been consistently associated with abnormalities in the Glutamate/Glutamine cycle. Our group has investigated BD patients during depressive episode and euthymia using magnetic resonance spectroscopy (1H-MRS). We developed a technic that allow a precise individual measure of GABA, glutamine and glutamate in the anterior cingulate cortex (ACC; 2×2×4.5 cm3) using a two-dimensional JPRESS sequence. Fifty euthymic patients and 24 bipolar depression patients were studied. GABA, glutamine (Gln) and glutamate (Glu) were quantified with the ProFit program. Our findings suggest a significant effect of anticonvulsant and lithium use on the glutamatergic system. The use of anticonvulsants was associated with increased glutamine levels in euthymic patients. Moreover, in bipolar depression treated with lithium those that achieved remmition presented higher myoinositol levels at endpoint and lithium increased glutamate levels. These results indicate that the glutamatergic function in BD patients is altered and suffers great influence of mood state and medication use. Overall, the present findings support a role for myoinositol and glutamate-glutamine cycling in the response to lithium and anticonvulsants in bipolar disorder. Further long-term studies are needed to investigate the effects of mood stabilizers on ACC metabolites, in special glutamate and its direct role in mediating plasticity activation associated with antidepressant response and mood stabilization.

Details

show
hide
Language(s):
 Dates: 2017-05
 Publication Status: Published in print
 Pages: -
 Publishing info: -
 Table of Contents: -
 Rev. Method: -
 Identifiers: DOI: 10.1111/bdi.09_12477
BibTex Citekey: SoeirodeSouzaHMMPLVO2017
 Degree: -

Event

show
hide
Title: 19th Annual Conference of the International Society for Bipolar Disorders (ISBD 2017)
Place of Event: Washington, DC, USA
Start-/End Date: -

Legal Case

show

Project information

show

Source 1

show
hide
Title: Bipolar Orders
Source Genre: Journal
 Creator(s):
Affiliations:
Publ. Info: -
Pages: - Volume / Issue: 19 (Supplement 1) Sequence Number: - Start / End Page: 25 - 25 Identifier: -